Skip to content

Acute Consumption of Pecan-enriched Meal

Comparison of Metabolic and Antioxidant Responses to a Breakfast Meal With and Without Pecans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04849962
Enrollment
24
Registered
2021-04-20
Start date
2017-08-10
Completion date
2018-02-27
Last updated
2021-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Pecans are a nutrient-dense food, but it is unknown whether substituting pecans for a portion of the butter in a traditional breakfast meal improves post-meal responses.

Detailed description

This study was a randomized, double-blind control trial consisting of 2 study visits for 2 different treatments. The treatments were high-fat breakfast muffins containing either butter (control) or pecans. The investigators recruited healthy, normal-weight adults between the ages of 15 and 45y. Study visits were completed in a random order with at least 72 hours between each visit. Anthropometrics, questionnaires, and fasting and postprandial blood samples were collected at each visit. Hypothesis: The pecan-enriched meal will blunt the post-meal increase in glucose, insulin, triglycerides (TG), and lipid peroxidation while improving all measures of subjective appetite and TAC compared to the traditional meal without nuts.

Interventions

OTHERControl

Participants in this group received a traditional muffin with butter as the predominant source of fat.

OTHERPecan

Participants in this group received a muffin in which part of the butter was substituted out for pecans.

Sponsors

University of Georgia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adult men and women * Normal-weight (body mass index = 18-24.9kg/m2)

Exclusion criteria

* Allergies to test meal ingredients (gluten, eggs, or nuts) * Medication/supplement usage * Chronic disease * Pregnancy or plans to become pregnant * Special diets * Tobacco use

Design outcomes

Primary

MeasureTime frameDescription
Change in triglycerides (TG) and glucoseChange from baseline to 3 hours postprandiallyTG (mg/dL) and glucose (mg/dL)
Change in lipid peroxidationChange from baseline to 3 hours postprandiallyMalondialdehyde (MDA) (uM) measured via Thiobarbituric acid reactive substances (TBARS) assay
Change in total antioxidant capacityChange from baseline to 3 hours postprandiallyTotal antioxidant capacity (uM trolox equivalents) measured via Oxygen Radical Absorbance Capacity (ORAC) assay.
Change in insulinChange from baseline to 3 hours postprandiallyInsulin (uU/mL)

Secondary

MeasureTime frameDescription
Change in angiopoietin-like proteins-3 (ANGPTL3) and -4 (ANGPTL4) responsesChange from baseline to 3 hours postprandiallyANGPTL3 (pg/mL) and ANGPTL4 (pg/mL)
Change in hunger and satiety responsesChange from baseline to 3 hours postprandiallyHunger, fullness, prospective consumption, and desire to eat measured via a Visual Analog Scale (VAS) (mm). The range of scores on the continuous VAS is 0-100 mm. Zero represents no hunger, fullness, prospective consumption, and desire to eat, while 100 represents the greatest feeling of these outcomes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026